Literature DB >> 16517907

Candida krusei transmission among hematology patients resolved by adapted antifungal prophylaxis and infection control measures.

Margreet C Vos1, Hubert P Endtz, Deborah Horst-Kreft, Jeanette Doorduijn, Elly Lugtenburg, Henri A Verbrugh, Bob Löwenberg, Siem de Marie, Cindy van Pelt, Alex van Belkum.   

Abstract

A sudden increase in neutropenic hematology patients with Candida krusei colonization and bacteremia prompted a longitudinal epidemiological investigation. We identified 39 patients; 13 developed candidemia, and three died; 25 patients carried the same genotype. We intervened by changing antifungal prophylaxis and implementing strict infection control measures. The incidence dropped immediately.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16517907      PMCID： PMC1393090          DOI： 10.1128/JCM.44.3.1111-1114.2006

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN： 0095-1137            Impact factor:   5.948


  11 in total

Review 1.  Nosocomial candidiasis: emerging species, reservoirs, and modes of transmission.

Authors:  M A Pfaller
Journal:  Clin Infect Dis       Date:  1996-05       Impact factor: 9.079

2.  Increase in Candida krusei infection among patients with bone marrow transplantation and neutropenia treated prophylactically with fluconazole.

Authors:  J R Wingard; W G Merz; M G Rinaldi; T R Johnson; J E Karp; R Saral
Journal:  N Engl J Med       Date:  1991-10-31       Impact factor: 91.245

3.  Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.

Authors:  J H Rex; T J Walsh; J D Sobel; S G Filler; P G Pappas; W E Dismukes; J E Edwards
Journal:  Clin Infect Dis       Date:  2000-04-20       Impact factor: 9.079

4.  [A Candida krusei epidemic in a hematology department].

Authors:  C Berger; R Frei; A Gratwohl; A Tichelli; B Häfliger; B Speck
Journal:  Schweiz Med Wochenschr       Date:  1988-01-16

5.  A highly polymorphic degenerate microsatellite for molecular strain typing of Candida krusei.

Authors:  Revital Shemer; Ziva Weissman; Nehama Hashman; Daniel Kornitzer
Journal:  Microbiology       Date:  2001-08       Impact factor: 2.777

6.  Candidemia in allogeneic blood and marrow transplant recipients: evolution of risk factors after the adoption of prophylactic fluconazole.

Authors:  K A Marr; K Seidel; T C White; R A Bowden
Journal:  J Infect Dis       Date:  2000-01       Impact factor: 5.226

7.  Molecular typing for investigating an outbreak of Candida krusei.

Authors:  G A Noskin; J Lee; D M Hacek; M Postelnick; B E Reisberg; V Stosor; S A Weitzman; L R Peterson
Journal:  Diagn Microbiol Infect Dis       Date:  1996 Nov-Dec       Impact factor: 2.803

Review 8.  Management of Candida species infections in critically ill patients.

Authors:  Philippe Eggimann; Jorge Garbino; Didier Pittet
Journal:  Lancet Infect Dis       Date:  2003-12       Impact factor: 25.071

9.  Has the epidemiology of nosocomial candidemia changed?

Authors:  Laura Puzniak; Steven Teutsch; William Powderly; Louis Polish
Journal:  Infect Control Hosp Epidemiol       Date:  2004-08       Impact factor: 3.254

Review 10.  Importance of Candida species other than C. albicans as pathogens in oncology patients.

Authors:  J R Wingard
Journal:  Clin Infect Dis       Date:  1995-01       Impact factor: 9.079
View more
  7 in total

1.  Canadian clinical practice guidelines for invasive candidiasis in adults.

Authors:  Eric J Bow; Gerald Evans; Jeff Fuller; Michel Laverdière; Coleman Rotstein; Robert Rennie; Stephen D Shafran; Don Sheppard; Sylvie Carle; Peter Phillips; Donald C Vinh
Journal:  Can J Infect Dis Med Microbiol       Date:  2010       Impact factor: 2.471

2.  The role of antibiotic stewardship in limiting antibacterial resistance among hematology patients.

Authors:  Inge C Gyssens; Winfried V Kern; David M Livermore
Journal:  Haematologica       Date:  2013-12       Impact factor: 9.941

3.  Development of a Multiplex PCR Short Tandem Repeat Typing Scheme for Candida krusei.

Authors:  Merlijn H I van Haren; Theun de Groot; Bram Spruijtenburg; Kusum Jain; Anuradha Chowdhary; Jacques F Meis
Journal:  J Clin Microbiol       Date:  2021-11-17       Impact factor: 11.677

4.  Candida krusei, a multidrug-resistant opportunistic fungal pathogen: geographic and temporal trends from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.

Authors:  M A Pfaller; D J Diekema; D L Gibbs; V A Newell; E Nagy; S Dobiasova; M Rinaldi; R Barton; A Veselov
Journal:  J Clin Microbiol       Date:  2007-12-12       Impact factor: 5.948

5.  Prolonged Outbreak of Candida krusei Candidemia in Paediatric Ward of Tertiary Care Hospital.

Authors:  Harsimran Kaur; Shamanth A Shankarnarayana; Vinaykumar Hallur; Jayashree Muralidharan; Manisha Biswal; Anup K Ghosh; Pallab Ray; Arunaloke Chakrabarti; Shivaprakash M Rudramurthy
Journal:  Mycopathologia       Date:  2020-01-25       Impact factor: 2.574

6.  Persistent candida arthritis successfully treated with micafungin instillation and surgery. A case report.

Authors:  Jeroen C van Egmond; Nicole G M Hunfeld; Bart J A Rijnders; Jan A N Verhaar
Journal:  Med Mycol Case Rep       Date:  2019-12-17

7.  A cluster of Candida krusei infections in a haematological unit.

Authors:  Timo Hautala; Irma Ikäheimo; Heidi Husu; Marjaana Säily; Timo Siitonen; Pirjo Koistinen; Jaana Vuopio-Varkila; Markku Koskela; Pekka Kujala
Journal:  BMC Infect Dis       Date:  2007-08-22       Impact factor: 3.090
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.